We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Celanese
CE
$4.87B
| $69.8M | 0.09% |
696,512
-27,968
| -4% | -$2.95M |
|
|
WCG
252
DELISTED
Wellcare Health Plans, Inc.
WCG
| $69.4M | 0.09% |
358,205
+184,819
| +107% | +$37M |
|
253
Neurocrine Biosciences
NBIX
$17.7B
| $69.2M | 0.09% |
834,998
+29,751
| +4% | +$2.51M |
|
254
Coca-Cola Europacific Partners
CCEP
$48.1B
| $68.7M | 0.09% |
1,650,048
+525,104
| +47% | +$20.7M |
|
255
Bristol-Myers Squibb
BMY
$128B
| $68.6M | 0.09% |
1,085,146
-678,554
| -38% | -$43.7M |
|
256
Veeco
VECO
$2.96B
| $68.3M | 0.09% |
4,015,028
+1,995,804
| +99% | +$34.7M |
|
257
M&T Bank
MTB
$36B
| $68.2M | 0.09% |
369,669
-28,296
| -7% | -$5.28M |
|
258
Watsco Inc
WSO
$15B
| $67.9M | 0.08% |
375,156
-88,099
| -19% | -$15.3M |
|
259
ON Semiconductor
ON
$34.7B
| $66.8M | 0.08% |
2,732,867
+73,929
| +3% | +$1.78M |
|
260
Exelon
EXC
$48.2B
| $66.5M | 0.08% |
2,390,482
+456,021
| +24% | +$12.3M |
|
261
Q2 Holdings
QTWO
$3.64B
| $66.5M | 0.08% |
1,459,814
+233,716
| +19% | +$10.1M |
|
262
Viatris
VTRS
$20.5B
| $66.2M | 0.08% |
1,607,915
+1,107,667
| +221% | +$47.2M |
|
|
AMID
263
DELISTED
American Midstream Partners, LP
AMID
| $65.8M | 0.08% |
6,094,590
+7,500
| +0.1% | +$95.4K |
|
264
Korn Ferry
KFY
$4.13B
| $65.5M | 0.08% |
1,268,871
+32,311
| +3% | +$1.44M |
|
|
UNIT
265
Uniti Group
UNIT
$2.62B
| $65.3M | 0.08% |
4,020,206
-310,161
| -7% | -$4.99M |
|
|
GWR
266
DELISTED
Genesee & Wyoming Inc.
GWR
| $65.2M | 0.08% |
921,491
+3,557
| +0.4% | +$268K |
|
|
ZNGA
267
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $64.9M | 0.08% |
17,743,566
-2,328,233
| -12% | -$8.59M |
|
268
Enbridge
ENB
$121B
| $63.7M | 0.08% |
2,023,455
+1,002,723
| +98% | +$35.1M |
|
269
Procter & Gamble
PG
$346B
| $63.2M | 0.08% |
797,567
+287,295
| +56% | +$24M |
|
|
BZUN
270
Baozun
BZUN
$164M
| $62.3M | 0.08% |
1,358,450
+94,480
| +7% | +$3.71M |
|
|
WCN
271
Waste Connections
WCN
$42.7B
| $62.2M | 0.08% |
866,839
+20,780
| +2% | +$1.48M |
|
272
Global Partners
GLP
$1.64B
| $61.5M | 0.08% |
4,007,613
+600
| +0% | +$10.3K |
|
273
Monolithic Power Systems
MPWR
$65.8B
| $61.4M | 0.08% |
530,734
+24,404
| +5% | +$2.89M |
|
274
ConocoPhillips
COP
$141B
| $60.7M | 0.08% |
1,022,993
-113,718
| -10% | -$6.43M |
|
275
Truist Financial
TFC
$63.7B
| $60.2M | 0.08% |
1,156,467
+1,031,619
| +826% | +$55.6M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.